Boai NKY (China) Performance
| 300109 Stock | 14.98 0.02 0.13% |
On a scale of 0 to 100, Boai NKY holds a performance score of 12. The firm shows a Beta (market volatility) of -0.8, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Boai NKY are expected to decrease at a much lower rate. During the bear market, Boai NKY is likely to outperform the market. Please check Boai NKY's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Boai NKY's price patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Boai NKY Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Boai NKY sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0668 | Payout Ratio 1.3023 | Last Split Factor 1.56:1 | Forward Dividend Rate 1 | Ex Dividend Date 2024-06-07 |
1 | United States N-VinylPyrrolidone Market Size, Share, Growth, Application Forecast - Third Eye News | 09/18/2024 |
| Begin Period Cash Flow | 492.9 M |
Boai |
Boai NKY Relative Risk vs. Return Landscape
If you would invest 1,083 in Boai NKY Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 415.00 from holding Boai NKY Pharmaceuticals or generate 38.32% return on investment over 90 days. Boai NKY Pharmaceuticals is generating 0.6387% of daily returns and assumes 3.9926% volatility on return distribution over the 90 days horizon. Simply put, 35% of stocks are less volatile than Boai, and 88% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Boai NKY Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boai NKY's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Boai NKY Pharmaceuticals, and traders can use it to determine the average amount a Boai NKY's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.16
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300109 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.99 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.64 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Boai NKY is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Boai NKY by adding it to a well-diversified portfolio.
Boai NKY Fundamentals Growth
Boai Stock prices reflect investors' perceptions of the future prospects and financial health of Boai NKY, and Boai NKY fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Boai Stock performance.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0651 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 7.34 B | ||||
| Shares Outstanding | 484.7 M | ||||
| Price To Book | 2.07 X | ||||
| Price To Sales | 4.86 X | ||||
| Revenue | 1.59 B | ||||
| Gross Profit | 690.63 M | ||||
| EBITDA | 671.45 M | ||||
| Net Income | 485.79 M | ||||
| Total Debt | 60.41 M | ||||
| Book Value Per Share | 7.23 X | ||||
| Cash Flow From Operations | 488.25 M | ||||
| Earnings Per Share | 0.79 X | ||||
| Total Asset | 4.02 B | ||||
| Retained Earnings | 1.01 B | ||||
About Boai NKY Performance
By analyzing Boai NKY's fundamental ratios, stakeholders can gain valuable insights into Boai NKY's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Boai NKY has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Boai NKY has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Boai NKY is entity of China. It is traded as Stock on SHE exchange.Things to note about Boai NKY Pharmaceuticals performance evaluation
Checking the ongoing alerts about Boai NKY for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Boai NKY Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Boai NKY appears to be risky and price may revert if volatility continues | |
| Boai NKY is unlikely to experience financial distress in the next 2 years | |
| About 25.0% of the company shares are owned by insiders or employees |
- Analyzing Boai NKY's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Boai NKY's stock is overvalued or undervalued compared to its peers.
- Examining Boai NKY's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Boai NKY's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Boai NKY's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Boai NKY's stock. These opinions can provide insight into Boai NKY's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Boai Stock analysis
When running Boai NKY's price analysis, check to measure Boai NKY's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boai NKY is operating at the current time. Most of Boai NKY's value examination focuses on studying past and present price action to predict the probability of Boai NKY's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boai NKY's price. Additionally, you may evaluate how the addition of Boai NKY to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |